Skip to Content

The Gap, Inc.

Company NameThe Gap, Inc.
Stock SymbolGPS
Class PeriodNovember 24, 2021 to July 11, 2022
Lead Plaintiff Motion DeadlineFebruary 03, 2023

On April 21, 2022, after the market closed, the Company announced that the CEO of Old Navy, Nancy Green, had stepped down. On this news, Gap’s stock price fell $2.57 per share, or 17%, to close at $11.72 per share on April 22, 2022, thereby injuring investors.

Then, on May 20, 2022, The Wall Street Journal published an article stating that Old Navy’s inclusive, extended sizing campaign, BODEQUALITY, had resulted in “too many extra-small and extra-large items and too few of the rest, a mismatch that frustrated customers and contributed to falling sales and a management shake-up.” The article also pointed out that Old Navy accounts for 54% of Gap’s sales and roughly 80% of the profits, and that Gap had warned that spring quarter sales would fall short of expectations because of troubles at Old Navy. On this news, Gap’s stock price fell $0.86, or 7.7%, to close at $10.33 per share on May 23, 2022, thereby injuring investors.

Then, on May 27, 2022, the Company released its first quarter 2022 financial results, admitting that the results had been “impacted by execution missteps in size and assortment at Old Navy related to BODEQUALITY,” as well as global supply chain disruptions. On this news, Gap’s stock price fell 4.9% to close at $11.03 per share on May 31, 2022.

Then, on July 11, 2022, after market hours, Gap announced that its President and CEO was stepping down from her position and had resigned from the Board of Directors. On this news, Gap’s stock price fell $0.44, or 5%, to close at %$8.32 per share on July 12, 2022, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) there were execution missteps in size and assortment at Old Navy related to BODEQUALITY which were adversely impacting Old Navy’s margins and financial results; (2) contrary to the Company’s statements, there were inventory risks relating to BODEQUALITY that were actually existing that were adversely affecting the Company’s operations; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Submit Your Information

If you suffered a loss on your The Gap, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd